Drug Discovery · Allschwil, Switzerland · Founded 2017 · Privately Held (backing)
Developer of cytokine therapeutics designed for the treatment of cancer and autoimmune diseases. Bright Peak Therapeutics is based in Allschwil, Switzerland and was founded in 2017. It has raised $244 million across 2 recorded rounds; the latest was a $90 million Series C in Jun 2024.
PMV mark · valuation
—
Oct 2026
Priced at
—
Total raised
$244.0M
Last round
Later Stage VC (Series C)
Jun 2024
Team — not yet on record
No current team members for Bright Peak Therapeutics are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Bright Peak Therapeutics with a free account
·The complete investor list: 12 names
·Watch Bright Peak Therapeutics: the Monday email on marks, rounds and moves
